K-134, a phosphodiesterase 3 inhibitor, reduces vascular inflammation and hypoxia, and prevents rupture of experimental abdominal aortic aneurysms

OBJECTIVE: Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease, which frequently results in fatal rupture; however, no pharmacologic treatment exists to inhibit AAA growth and prevent rupture. In this study, we investigated whether K-134, a novel phosphodiesterase 3 inhibitor, could li...

Descripción completa

Detalles Bibliográficos
Autores principales: Unno, Naoki, Tanaka, Hiroki, Yata, Tatsuro, Kayama, Takafumi, Yamanaka, Yuta, Tsuyuki, Hajime, Sano, Masaki, Inuzuka, Kazunori, Naruse, Ena, Takeuchi, Hiroya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Basic Reserch Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489215/
https://www.ncbi.nlm.nih.gov/pubmed/34617050
http://dx.doi.org/10.1016/j.jvssci.2020.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489215/
https://www.ncbi.nlm.nih.gov/pubmed/34617050
http://dx.doi.org/10.1016/j.jvssci.2020.09.005

Ejemplares similares